A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide.

Trial Profile

A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Lacosamide (Primary) ; Fosphenytoin
  • Indications Seizures
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Jan 2012 Actual patient number is 11 according to ClinicalTrials.gov.
    • 23 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top